8-K: Odyssey Health, Inc. Confirms FINRA Approval for Corporate Name Change on OTC Markets

Odyssey Health, Inc. announced that FINRA has approved its name change on the OTC Markets, effective May 27, 2025, with the trading symbol ODYY remaining unchanged.

Summary

• Odyssey Health, Inc. (formerly Odyssey Group International, Inc.) reported that the Financial Industry Regulatory Authority (FINRA) approved its name change on the OTC Markets.
• The name change on the OTC Markets will become effective on May 27, 2025.
• The company's OTC Market trading symbol, ODYY, will remain the same.
• Shareholders had approved this name change at their annual meeting on September 14, 2021.
• The State of Nevada effectuated the name change via an amendment to the Articles of Incorporation filed on December 1, 2021, which was effective as of October 8, 2021.

Sentiment

Score: 6

Explanation: The document reports a standard administrative corporate action (name change approval) which is generally neutral but can be seen as a positive step towards corporate identity alignment and operational clarity. There are no negative financial or operational implications mentioned.

Positives

• The approval of the name change by FINRA provides clarity and consistency for the company's identity on the OTC Markets.
• The retention of the existing trading symbol 'ODYY' avoids potential confusion for investors and ensures continuity.

Future Outlook

The document does not provide specific forward-looking statements or guidance beyond the effective date of the name change on the OTC Markets.

Management Comments

• Joseph Michael Redmond, Chief Executive Officer, signed the report on behalf of Odyssey Health, Inc.

Industry Context

This administrative update reflects a standard corporate action for companies undergoing a rebranding or strategic shift, ensuring their public trading identity aligns with their corporate legal name. Such changes are common across various industries and are typically reported to maintain transparency with investors and regulatory bodies.

Comparison to Industry Standards

• The process of obtaining FINRA approval for a name change on public markets is a standard regulatory procedure for companies listed on OTC Markets, similar to requirements for companies on major exchanges like NASDAQ or NYSE.
• The timeline from shareholder approval (September 2021) to FINRA approval (May 2025) for market-level implementation, while extended, is not uncommon given the various state and regulatory steps involved in corporate identity changes.

Corporate Governance

Stakeholder Impact

• Shareholders: The name change provides clarity on the company's identity and aligns its trading name with its legal name, potentially reducing confusion.
• Investors: The retention of the 'ODYY' trading symbol ensures continuity and ease of identification for current and prospective investors.

Next Steps

• The name change will become effective on the OTC Markets on May 27, 2025.

Key Dates

Recommendation

Keywords

Odyssey Health, Odyssey Group International, FINRA approval, name change, OTC Markets, ODYY, corporate governance, SEC filing, 8-K